Image: CSIC.These compounds are more versatile modulators of cytokine production and have longer life than alpha-galactosylceramide. They have potential as vaccine adjuvants and drugs for autoimmune diseases, infections or cancer. Pharmaceutical and biotechnological companies are sought to collaborate under a patent license.
Contact:
Vicepresidencia Adjunta
de Transferencia del Conocimiento CSIC
Institut de Química Avançada de Catalunya
Isabel Massip
Tel. +(34) 93 400 61 00